Single nucleotide variant at the alphaVbeta3 integrin associated to Andes virus infection susceptibility.
Constanza Martinez-ValdebenitoiD, Jenniffer Angulo, N. Le Corre, Clauda Marco, Cecilia VialiD, JF Miquel, Jaime Cerda, Gregory Mertz, Pablo Vial, Marcelo Lopez-LastraiD, Marcela Ferres, F. Valdivieso, R. Riquelme,ML Rioseco, M. Calvo, F. Vargas, M. Acuña, R. Mansilla, C. Infante
Abstract
BackgroundANDV, agent of hantavirus cardiopulmonary syndrome, enters through integrin cell protein. A change from leucine-to-proline at residues 33 in the PSI-domain (L33P) inhibits ANDV recognition. We assessed the association between this human-variant and ANDV infection.\n\nResultsWe defined susceptible genotype to \"TT\" (coding leucine) and protective \"CC\" (coding proline). TT was in 89.2% (66/74) of a first cohort of ANDV-cases and in 60% (63/105) of exposed close-household contacts who remained unifected (p<0.05). Protective genotype was absent in all 85 ANDV cases in both cohorts and was present at 11.4% in exposed close-household contacts who remained uninfected. Logistic regression modeling to become a case had an OR 6.2-12.6 (p<0.05) in presence of TT and ANDV well-known risk activities. Moreover, OR of 7.3 was obtained when TT condition was analyzed for two groups exposed to the same environmental risk.\n\nConclusionHost genetic background has an important role in ANDV-infection susceptibility in the studied population.\n\nAuthor summaryHantavirus is a worldwide infection known to cause two different diseases: the hemorrhagic fever with renal syndrome (HFRS) and hantavirus cardiopulmonary syndrome (HCPS or HPS), diseases seen in the old world and new world hantaviruses, respectively. Andes orthohantavirus (ANDV), is the etiological agent of HCPS in Chile and South of Argentina, and is the only hantavirus recognized to be transmited person-to-person. It has been suggested that {beta}3-integrin is a cellular receptor for ANDV entry into cells. Here we try to understand the role of one human genetic variant of {beta}3-integrin in susceptibility to ANDV-infection. We compared, exposed infected and non infected subjects, and their genotype differences regarding a {beta}3 integrin variant that change a Leucine to Proline at PSI domain of the receptor. Leucine and proline aminoacids at the PSI domain, turn the cell susceptible or resistant to ANDV-infection, respectively. We were able to show genotype differences in cases and close-household contact that suggest differences in ANDV-infection susceptibility. Our results propose that the TT genotype, that codes to leucine, is a risk factor to become infected with ANDV, and the CC genotype that codes for proline at PSI domain, is a protective factor. (193/200)
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Two point mutations in protocadherin-1 disrupt Andes hantavirus recognition and afford protection against lethal infection
M. M. Slough, R. Li, … K. Chandran·bioRxiv·Jul 19, 2022
- Andes virus genome mutations that are likely associated with animal-model attenuation and human person-to-person transmission
C. Bellomo, D. Alonso, … V. Martinez·bioRxiv·Jan 18, 2023
- Andes virus from the MV Hondius outbreak is highly pathogenic in hamsters and airborne shed
Melanie Rissmann, Maarten F. Wilbrink, … Massimo Palmarini·bioRxiv·Oct 13, 2026
- T-cell immunoglobulin and mucin (TIM) contributes to Hantaan virus entry into human airway epithelial cells
J. Mayor, G. Torriani, … O. Engler·bioRxiv·Dec 11, 2019
- Genetic depletion studies define receptor usage by virulent hantaviruses in human endothelial cells
M. E. Dieterle, C. Sola-Riera, … K. Chandran·bioRxiv·Dec 30, 2020
- Expanded protocadherin-1 usage reveals a broader hantavirus entry landscape
Cierra Word, Nahomi Guerra-Pilaquinga, … Rohit K. Jangra·Journal of VirologyPeer-reviewed·Sep 29, 2026